Leukemia
A Phase 1/2, Open-Label, Dose-Escalation, Dose-Expansion Study of DSP-5336 in Adult Patients with Acute Leukemia and Other Selected Hematologic Malignancies, with and without Mixed Lineage Leukemia (MLL) rearrangement or Nucleophosmin 1 (NPM1) Mutation (DSP-5336-101)
- Details
ClinicalTrials.gov ID:
NCT04988555
Diagnosis Type:
NA
USOR Number:
- Address
,
P: